Base Molecular Resonance™ Technologies Offers U.S.A. a Generational Edge Against Next-Gen Warfare
Built utilizing its multi-patented Base Molecular Resonance™ technology, BMRT's systems can remotely detect explosives, narcotics, DNA (for human trafficking), high-value threats, and weaponized drones through steel containers, ship hulls, and sealed cargo bays, with zero false positives or negatives, and no need to open or unload freight, whether up close or at a distance. This revolutionary platform is so advanced that it can detect every element on the periodic table, as well as over 200 types of cancers and other diseases.
On
"We've entered a new era of warfare," said Robert 'Bo' Short, Co-Founder and CEO of BMRT. "The recent Ukrainian drone assault exposed how easily adversaries can weaponize ordinary shipping containers to carry out high-impact attacks from seemingly benign locations. In this new battlespace, traditional defense methods fall short. BMRT's technology exposes these threats before they can strike. This scientific innovation provides the strategic advantage our nation requires to maintain its position as the world's greatest military power."
BMRT's Multi-Patented, Independently Validated Technology Delivers What Traditional Systems Cannot.
BMRT's breakthrough has been validated in a blind and double-blind study by the Centre for Applied Innovation at York St. John University in
It can detect explosive compounds and threat components hidden inside sealed containers, cages, and compartments without manual searches, visual inspection, or physical contact. Detection is instantaneous and non-intrusive, eliminating delay, disruption, and uncertainty.
With over 11 million containers entering
Strategic and Commercial Value
BMRT's Base Molecular Resonance™ platform has received an independent intellectual property valuation of
For more information, visit www.BMRT.io
Investment Inquiries
Robert "Bo "Short
Co-Founder & CEO
[email protected]
Media Contact
Chief Marketing Officer
[email protected]
800.522.4718 Ext. 1
About Base Molecular Resonance™ Technologies (BMRT)
BMRT has discovered a new area of quantum physics that utilizes resonant frequencies to detect particle interactions at subatomic levels. This technology, called Base Molecular Resonance™ (BMR™), can detect any compound or biological substance, including every element on the periodic table, and up to 200 cancers and other diseases. With over 20 years of prototyping and testing proving its unmatched detection capabilities, BMR™ has the potential to save millions of lives by pinpointing weapons, explosives, and other physical threats both up close and at great distances, and detecting cancers and other diseases long before they present clinical symptoms. The non-invasive, harmless, and instant scan has broad implications in cancer diagnostics, public safety, law enforcement, security, and military services.
View original content to download multimedia:https://www.prnewswire.com/news-releases/base-molecular-resonance-technologies-offers-usa-a-generational-edge-against-next-gen-warfare-302479476.html
SOURCE Base Molecular Resonance Technologies, LLC
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Alphio.AI Innovates Retail Trading with an AI-Native Workspace and Non-Custodial Execution
- vAuto Launches Test Drive, New Initiative to Scale and Speed Product Innovations
- Novavax's Partnership Strategy Continues to Deliver with XFG-adapted Nuvaxovid™ Approvals in the U.S., EU and Japan for 2026-2027 Vaccination Season
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share